• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒毒素时代膀胱顺应性差的管理变化

Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.

作者信息

Prakash Nachiketh Soodana, Lopategui Diana M, Gomez Christopher

机构信息

Department of Urology, Miller School of Medicine University of Miami, Miami, FL, USA.

出版信息

Curr Urol Rep. 2017 Aug;18(8):64. doi: 10.1007/s11934-017-0707-6.

DOI:10.1007/s11934-017-0707-6
PMID:28689244
Abstract

Bladder compliance is a measure of distensibility. Maladies such as myelodysplasia, myelomeningocele, spinal cord injury, multiple sclerosis and obstructive uropathy are known to decrease bladder compliance. Decrease in bladder compliance is a characteristic of neurogenic bladders. The pathophysiology of bladder compliance is complex but ultimately leads to high pressure during filling and storage phases. These high pressures lead to renal impairment, incontinence, and recurrent urinary tract infections. This review presents management of poorly compliant bladders with onabotulinumtoxinA.

摘要

膀胱顺应性是对扩张性的一种衡量。诸如脊髓发育不良、脊髓脊膜膨出、脊髓损伤、多发性硬化症和梗阻性尿路病等疾病已知会降低膀胱顺应性。膀胱顺应性降低是神经源性膀胱的一个特征。膀胱顺应性的病理生理学很复杂,但最终会导致充盈期和储尿期的高压。这些高压会导致肾功能损害、尿失禁和反复的尿路感染。本综述介绍了用A型肉毒毒素治疗顺应性差的膀胱的方法。

相似文献

1
Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era.A型肉毒毒素时代膀胱顺应性差的管理变化
Curr Urol Rep. 2017 Aug;18(8):64. doi: 10.1007/s11934-017-0707-6.
2
Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).第5章:神经源性逼尿肌过度活动(NDO)和膀胱过度活动症(OAB)的临床数据。
Neurourol Urodyn. 2014 Jul;33 Suppl 3:S26-31. doi: 10.1002/nau.22630.
3
Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.经尿道前列腺切除术治疗良性前列腺增生术后出血的危险因素分析
Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.
4
Botulinum injection is useless on fibrotic neuropathic bladders.肉毒杆菌注射对纤维化神经性膀胱无效。
J Pediatr Urol. 2015 Feb;11(1):27.e1-4. doi: 10.1016/j.jpurol.2014.08.009. Epub 2014 Sep 28.
5
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.肉毒杆菌毒素 A 100U 显著改善伴有尿急和尿失禁的膀胱过度活动症患者的所有特发性膀胱过度活动症症状和生活质量:一项随机、双盲、安慰剂对照试验。
Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10.
6
Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction.经尿道内注射肉毒毒素(300 单位)治疗成人神经源性下尿路功能障碍患者顺应性差的膀胱。
Neurourol Urodyn. 2020 Nov;39(8):2322-2328. doi: 10.1002/nau.24490. Epub 2020 Aug 31.
7
Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.A型肉毒杆菌毒素与神经源性尿失禁:若安全使用,有时有益。
Prescrire Int. 2013 Jan;22(134):12-3.
8
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.肉毒毒素 A 能改善神经原性逼尿肌过度活动患者的尿动力学结果。
Neurourol Urodyn. 2013 Nov;32(8):1109-15. doi: 10.1002/nau.22376. Epub 2013 Feb 6.
9
Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study.经尿道内与膀胱下注射肉毒毒素 A 治疗神经源性逼尿肌过度活动症:一项初步研究。
Spinal Cord. 2012 Dec;50(12):904-7. doi: 10.1038/sc.2012.76. Epub 2012 Jul 17.
10
[Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].[毒素A肉毒杆菌治疗脊髓脊膜膨出继发神经源性膀胱患儿顽固性膀胱活动亢进的疗效:肠膀胱扩大术的替代方法]
Minerva Pediatr. 2005 Feb;57(1):35-40.

引用本文的文献

1
Evaluating the Efficacy and Safety of Botulinum Toxin in Treating Overactive Bladder in the Elderly: A Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials.评价肉毒杆菌毒素治疗老年患者膀胱过度活动症的疗效和安全性:一项随机对照试验的荟萃分析及试验序贯分析。
Toxins (Basel). 2024 Nov 8;16(11):484. doi: 10.3390/toxins16110484.
2
Irreversible Bladder Remodeling Induced by Fibrosis.纤维化诱导的不可逆膀胱重塑
Int Neurourol J. 2021 May;25(Suppl 1):S3-7. doi: 10.5213/inj.2142174.087. Epub 2021 May 31.
3
Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?

本文引用的文献

1
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A.肉毒杆菌毒素A治疗神经源性膀胱患者无症状菌尿的不同抗生素方案比较
Braz J Infect Dis. 2016 Nov-Dec;20(6):623-626. doi: 10.1016/j.bjid.2016.08.012. Epub 2016 Oct 18.
2
Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia.A型肉毒杆菌毒素注射对脊髓损伤合并逼尿肌过度活动和逼尿肌括约肌协同失调患者的影响。
J Rehabil Med. 2016 Oct 5;48(8):683-687. doi: 10.2340/16501977-2132.
3
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
重复注射A型肉毒杆菌毒素会改善慢性脊髓损伤患者的逼尿肌过度活动和膀胱顺应性吗?
Tzu Chi Med J. 2020 Jul 29;33(2):101-107. doi: 10.4103/tcmj.tcmj_77_20. eCollection 2021 Apr-Jun.
4
Conservative management of bladder endometriosis with acute renal failure.膀胱子宫内膜异位症合并急性肾衰竭的保守治疗
Urol Case Rep. 2020 May 19;33:101263. doi: 10.1016/j.eucr.2020.101263. eCollection 2020 Nov.
5
Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis.遗传性转甲状腺素蛋白淀粉样变性相关泌尿系统和性功能障碍的诊断和治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):65-74. doi: 10.1007/s10286-019-00627-7. Epub 2019 Aug 26.
6
Conservative management of hostile bladders with intravesical botulinum toxin for successful renal transplantation.采用膀胱内注射肉毒杆菌毒素对难治性膀胱进行保守治疗以成功进行肾移植。
Urol Case Rep. 2018 Oct 25;22:73-75. doi: 10.1016/j.eucr.2018.10.017. eCollection 2019 Jan.
经尿道注射肉毒毒素 A 治疗难治性神经源性逼尿肌过度活动症:15 年以上经验教训。
Eur Urol. 2016 Sep;70(3):522-8. doi: 10.1016/j.eururo.2016.03.052. Epub 2016 Apr 19.
4
Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment.神经原性逼尿肌过度活动患者完成 4 年治疗后接受肉毒毒素 A 治疗的长期疗效和安全性。
J Urol. 2016 Sep;196(3):801-8. doi: 10.1016/j.juro.2016.04.046. Epub 2016 Jun 2.
5
Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.脊髓损伤患者接受A型肉毒毒素治疗后膀胱相关自主神经反射障碍的减轻
J Neurotrauma. 2016 Sep 15;33(18):1651-7. doi: 10.1089/neu.2015.4278. Epub 2016 Apr 13.
6
Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.A型肉毒毒素时代下扩大膀胱成形术的适应症
Curr Urol Rep. 2016 Apr;17(4):27. doi: 10.1007/s11934-016-0585-3.
7
Management of Low Compliant Bladder in Spinal Cord Injured Patients.
Low Urin Tract Symptoms. 2010 Sep;2(2):61-70. doi: 10.1111/j.1757-5672.2010.00076.x. Epub 2010 Jul 30.
8
Neurogenic bladder in spinal cord injury patients.脊髓损伤患者的神经源性膀胱
Res Rep Urol. 2015 Jun 10;7:85-99. doi: 10.2147/RRU.S29644. eCollection 2015.
9
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.肉毒杆菌毒素在神经源性逼尿肌过度活动患者中的应用:最新综述
J Spinal Cord Med. 2013 Sep;36(5):402-19. doi: 10.1179/2045772313Y.0000000116.
10
OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity.肉毒毒素 A 能改善神经原性逼尿肌过度活动患者的生活质量。
Neurology. 2013 Aug 27;81(9):841-8. doi: 10.1212/WNL.0b013e3182a2ca4d. Epub 2013 Jul 26.